Form D Explorer
Elucid Bioimaging Inc. · CIK 1585931

Report a data issueCitable research briefCompare issuerPrivate research collection

Elucid Bioimaging Inc.

CIK 1585931 · Corporation · Inc. DELAWARE · BOSTON, Massachusetts · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
1
Amendments
1
Activity
Oct 22, 2025
through Oct 27, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldOct 22, 2025 · DOct 27, 2026 · D/ALater minus earlier
Reported offering amount$79,999,999$79,999,999$0
Reported amount sold$36,495,008$56,235,000$19,739,992
Reported investor count—20—
Reported minimum investment$0$0$0

Earlier SEC source: 0002080612-25-000007 · Later SEC source: 0002080612-26-000057

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Oct 27, 2026

Reported offering amount
$79,999,999
Reported exemptions
Rule 506(b)
Reported amount sold
$56,235,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)